ENOR vs BIB
Comparison between ISHARES MSCI NORWAY ETF (ENOR, ETF) and PROSHARES ULTRA NASDAQ BIOTECHNOLOGY (BIB, ETF).
5-Year PerformanceENOR has outperformed BIB, delivering a return of +9.2% compared to +0.4%
ENOR vs BIB - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Net Assets
ENOR
$84M
Winner
BIB
$84M
Expense Ratio
ENOR
0.53%
BIB
N/A
Max Drawdown
Winner
ENOR
62.59%
BIB
67.24%
Sharpe Ratio
ENOR
1.40
Winner
BIB
1.82
5Y Beta
Winner
ENOR
0.66
BIB
1.50
P/E Ratio
ENOR
N/A
BIB
-42.89
5Y Dividends CAGR
ENOR
19.10%
BIB
N/A
Debt to Equity
ENOR
N/A
BIB
67.65%
P/S Ratio
ENOR
N/A
BIB
7.09
P/B Ratio
ENOR
N/A
BIB
5.22
ENOR vs BIB - Holdings Comparison
ENOR and BIB have 1 common holdings. Overlap is -0.13%
ENOR's top 25 holdings weight is 84.18%. BIB's top 25 holdings weight is 75.10%.
| Rank | ENOR | BIB |
|---|---|---|
| #1 | EQUINOR ASA (n/a) - 11.80% | NASDAQ BIOTECHNOLOGY INDEX SWAP (n/a) - 21.23% |
| #2 | DNB BANK ASA (n/a) - 11.51% | CASH (n/a) - 9.46% |
| #3 | KONGSBERG GRUPPEN ASA (n/a) - 5.58% | PROSHARES GENIUS MONEY MARKET ETF (IQMM) - 5.98% |
| #4 | NORSK HYDRO ASA (n/a) - 5.47% | VERTEX PHARMACEUTICALS INC (VRTX) - 4.57% |
| #5 | AKER BP ASA (n/a) - 4.90% | AMGEN INC (AMGN) - 4.41% |
| #6 | TELENOR ASA (n/a) - 4.33% | NASDAQ BIO INDEX SWAP (n/a) - 3.97% |
| #7 | MOWI ASA (n/a) - 3.92% | GILEAD SCIENCES INC (GILD) - 3.85% |
| #8 | ORKLA ASA (n/a) - 3.67% | CTE PROSHARES TRUST M (n/a) - 3.34% |
| #9 | STOREBRAND ASA (n/a) - 3.63% | REGENERON PHARMACEUTICALS INC (REGN) - 2.52% |
| #10 | YARA INTERNATIONAL ASA (n/a) - 3.57% | ALNYLAM PHARMACEUTICALS INC (ALNY) - 1.58% |
| #11 | SUBSEA 7 SA (n/a) - 3.52% | REVOLUTION MEDICINES INC ORDINARY SHARES (RVMD) - 1.56% |
| #12 | GJENSIDIGE FORSIKRING ASA (n/a) - 2.70% | BIOGEN INC (BIIB) - 1.21% |
| #13 | FRONTLINE PLC (FRO) - 2.61% | MODERNA INC (MRNA) - 1.13% |
| #14 | SPAREBANK 1 SOR NORGE ASA (n/a) - 2.00% | ILLUMINA INC (ILMN) - 1.09% |
| #15 | VAR ENERGI ASA (n/a) - 1.97% | ROIVANT SCIENCES LTD ORDINARY SHARES (ROIV) - 0.99% |
| #16 | VEND MARKETPLACES ASA ORDINARY SHARES (n/a) - 1.92% | ARGENX SE ADR (ARGX) - 0.98% |
| #17 | SALMAR ASA (n/a) - 1.54% | ROYALTY PHARMA PLC CLASS A (RPRX) - 0.97% |
| #18 | NORDIC SEMICONDUCTOR ASA (n/a) - 1.41% | UNITED THERAPEUTICS CORP (UTHR) - 0.91% |
| #19 | AKER ASA CLASS A (n/a) - 1.36% | INSMED INC (INSM) - 0.91% |
| #20 | TGS ASA (n/a) - 1.26% | GUARDANT HEALTH INC (GH) - 0.89% |
| #21 | PROTECTOR FORSIKRING ASA (n/a) - 1.20% | INCYTE CORP (INCY) - 0.89% |
| #22 | SPAREBANK 1 SMN DEPOSITORY RECEIPTS (n/a) - 1.13% | VIATRIS INC (VTRS) - 0.74% |
| #23 | KONGSBERG MARITIME ASA (n/a) - 1.12% | NEUROCRINE BIOSCIENCES INC (NBIX) - 0.66% |
| #24 | BAKKAFROST P/F (n/a) - 1.03% | ASCENDIS PHARMA AS (ASND) - 0.65% |
| #25 | TOMRA SYSTEMS ASA (n/a) - 1.03% | MEDPACE HOLDINGS INC (MEDP) - 0.61% |
| Total Holdings | 65 | 258 |
ENOR vs BIB - Historical Returns
Returns include dividend reinvestment.
1M
ENOR
+6.03%
Winner
BIB
+10.35%
3M
ENOR
-2.36%
Winner
BIB
+17.09%
6M
Winner
ENOR
+16.39%
BIB
+15.53%
1Y
ENOR
+28.90%
Winner
BIB
+87.65%
5Y(CAGR)
Winner
ENOR
+9.22%
BIB
+0.42%
10Y(CAGR)
Winner
ENOR
+9.41%
BIB
+8.25%
Max(CAGR)
ENOR
+5.73%
Winner
BIB
+17.36%
ENOR vs BIB - Annual Returns (2010 - 2026)
Returns include dividend reinvestment.
| Year | ENOR | BIB |
|---|---|---|
| 2026 | +22.30% | +24.37% |
| 2025 | +30.35% | +57.12% |
| 2024 | -0.30% | -13.29% |
| 2023 | +8.03% | +0.43% |
| 2022 | -13.40% | -29.88% |
| 2021 | +18.51% | -4.77% |
| 2020 | +1.24% | +41.55% |
| 2019 | +12.25% | +43.60% |
| 2018 | -9.35% | -28.47% |
| 2017 | +20.83% | +35.43% |
| 2016 | +19.07% | -40.15% |
| 2015 | -15.90% | +11.86% |
| 2014 | -20.31% | +66.93% |
| 2013 | +7.44% | +144.02% |
| 2012 | +17.29% | +64.72% |
| 2011 | N/A | +13.41% |
| 2010 | N/A | +0.29% |
ENOR vs BIB Drawdown Comparison
The maximum drawdown for ENOR was -55.31%, occurring on Mar 18, 2020. Recovery took 1726 trading sessions.
The maximum drawdown for BIB was -67.24%, occurring on Jun 27, 2016. Recovery took 1389 trading sessions.
The current ENOR drawdown is -5.80%. The current BIB drawdown is -9.84%.
| Rank | ENOR | BIB |
|---|---|---|
| #1 | -55.31% Jun 6, 2014 - Apr 15, 2021 | -67.24% Jul 20, 2015 - Jan 25, 2021 |
| #2 | -32.61% Mar 30, 2022 - May 21, 2025 | -66.19% Feb 8, 2021 - Jul 7, 2026 |
| #3 | -24.65% Mar 20, 2012 - Jan 2, 2013 | -40.88% May 12, 2011 - Jan 18, 2012 |
| #4 | -14.48% May 21, 2026 - Jun 26, 2026 | -39.01% Feb 25, 2014 - Sep 24, 2014 |
| #5 | -13.96% Feb 1, 2013 - Sep 18, 2013 | -36.30% Apr 15, 2010 - Dec 17, 2010 |
| #6 | -13.29% Oct 20, 2021 - Mar 30, 2022 | -24.73% Oct 5, 2012 - Mar 1, 2013 |
| #7 | -9.93% Jun 7, 2021 - Oct 13, 2021 | -20.33% May 14, 2013 - Jul 11, 2013 |
| #8 | -9.13% Oct 25, 2013 - Mar 5, 2014 | -17.74% Mar 20, 2015 - Jun 18, 2015 |
| #9 | -9.01% Sep 16, 2025 - Jan 2, 2026 | -17.57% Oct 1, 2013 - Nov 22, 2013 |
| #10 | -7.29% Feb 28, 2012 - Mar 20, 2012 | -16.83% Sep 24, 2014 - Oct 23, 2014 |
| #11 | -6.49% Sep 18, 2013 - Oct 18, 2013 | -13.85% Dec 19, 2014 - Jan 20, 2015 |
| #12 | -5.50% Mar 19, 2026 - Mar 31, 2026 | -13.72% Aug 2, 2013 - Sep 5, 2013 |
| #13 | -5.48% Jun 13, 2025 - Aug 22, 2025 | -13.27% Jan 22, 2014 - Feb 11, 2014 |
| #14 | -5.32% Apr 29, 2021 - Jun 1, 2021 | -13.06% Dec 9, 2014 - Dec 19, 2014 |
| #15 | -5.00% Mar 6, 2014 - Apr 24, 2014 | -11.91% Jul 7, 2026 - Jul 20, 2026 |
Correlation
Correlation between ENOR and BIB is 0.41 which considered as a weak positive correlation - the stocks show a slight tendency to move together.
0.41
-101
Dividend Comparison (2010 - 2026)
ENOR vs BIB dividend yield comparison.
| Year | ENOR | BIB |
|---|---|---|
| 2026 | 4.55% | 0.01% |
| 2025 | 2.96% | 0.77% |
| 2024 | 6.32% | 1.69% |
| 2023 | 5.06% | 0.07% |
| 2022 | 4.02% | 0.03% |
| 2021 | 2.24% | 0.00% |
| 2020 | 2.39% | 0.00% |
| 2019 | 3.15% | 0.00% |
| 2018 | 2.79% | 0.00% |
| 2017 | 2.47% | 0.00% |
| 2016 | 2.96% | 0.00% |
| 2015 | 3.24% | 0.00% |
| 2014 | 4.52% | 0.00% |
| 2013 | 2.65% | 0.00% |
| 2012 | 2.66% | 0.00% |
| 2010 | 0.00% | 0.15% |
Select Stocks to Compare
Popular: ENOR vs SPYBIB vs SPY
More Comparisons
Compare with similar stocks